This activity is supported by independent educational grants from Abbott Diabetes Care, Dexcom, Lilly, Medtronic, and Novo Nordisk.
Learning Objectives:
Assess  differences between available continuous glucose monitors and the appropriate settings for implementing the use of diabetes technologies
Identify interventions which can add value to A1c interpretation and optimize time-in-range glucose values to improve patient outcomes
Integrate diabetes technologies into clinical practice and harness these devices to improve glycemia, guide patient education and empower patients to self-manage their diabetes